Monday, June 18, 2018 6:16:12 PM
It seems like there is a better explanation for what we are seeing here, without the requisite evidence.
Recent CELZ News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2025 09:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:42 PM
- Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits • GlobeNewswire Inc. • 10/30/2025 01:15:00 PM
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds • GlobeNewswire Inc. • 10/29/2025 01:00:00 PM
- Creative Medical Technology Holdings Issues Letter to Shareholders • GlobeNewswire Inc. • 10/27/2025 12:15:00 PM
- Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs • GlobeNewswire Inc. • 10/07/2025 01:15:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/15/2025 01:01:31 AM
- Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain • GlobeNewswire Inc. • 08/13/2025 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:45:55 PM
- Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells • GlobeNewswire Inc. • 07/17/2025 01:15:00 PM
- Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling • GlobeNewswire Inc. • 07/11/2025 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 08:45:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 08:30:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/25/2025 08:45:21 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/04/2025 09:00:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2025 08:48:34 PM
- Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain • GlobeNewswire Inc. • 03/20/2025 11:50:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/19/2025 09:04:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/14/2025 08:35:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/14/2025 08:30:22 PM
Isiah Thomas Marks Historic Milestone: First NBA Player With Majority Control of a Public Company • OWPC • Nov 6, 2025 12:23 PM
EVTV Takes Flight in Europe: U.S. Heavy-Lift Drones to Disrupt Traditional Vineyard Operations Across Italy • EVTV • Nov 6, 2025 8:19 AM
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment • AVAI • Nov 4, 2025 8:46 AM
ECGI Holdings Signs Binding $30 Million LOI to Acquire Licensed Mortgage Lender RezyFi • ECGI • Nov 3, 2025 8:30 AM
One World Products Secures OEM Approval for Cellulose Fiber-Filled Masterbatch for Future Vehicle Programs • OWPC • Nov 3, 2025 8:15 AM
From Explorer to Producer: The Most Compelling Mining Window • ABMBF • Oct 30, 2025 9:00 AM
